134 related articles for article (PubMed ID: 11819117)
1. Identification and expression of HySmad1, a member of the R-Smad family of TGFbeta signal transducers, in the diploblastic metazoan Hydra.
Hobmayer B; Rentzsch F; Holstein TW
Dev Genes Evol; 2001 Dec; 211(12):597-602. PubMed ID: 11819117
[TBL] [Abstract][Full Text] [Related]
2. Intracellular dynamics of Smad-mediated TGFbeta signaling.
Greene RM; Nugent P; Mukhopadhyay P; Warner DR; Pisano MM
J Cell Physiol; 2003 Nov; 197(2):261-71. PubMed ID: 14502566
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of Smad2 is required for enhancement of TGFbeta/Smad signaling by TGFbeta inducible early gene.
Johnsen SA; Subramaniam M; Katagiri T; Janknecht R; Spelsberg TC
J Cell Biochem; 2002; 87(2):233-41. PubMed ID: 12244575
[TBL] [Abstract][Full Text] [Related]
4. Budhead, a fork head/HNF-3 homologue, is expressed during axis formation and head specification in hydra.
Martinez DE; Dirksen ML; Bode PM; Jamrich M; Steele RE; Bode HR
Dev Biol; 1997 Dec; 192(2):523-36. PubMed ID: 9441686
[TBL] [Abstract][Full Text] [Related]
5. Structural insights on Smad function in TGFbeta signaling.
Shi Y
Bioessays; 2001 Mar; 23(3):223-32. PubMed ID: 11223879
[TBL] [Abstract][Full Text] [Related]
6. [Morphogenesis of Hydra].
Fujisawa T
Tanpakushitsu Kakusan Koso; 2005 May; 50(6 Suppl):588-94. PubMed ID: 15926485
[No Abstract] [Full Text] [Related]
7. Smads and chromatin modulation.
van Grunsven LA; Verstappen G; Huylebroeck D; Verschueren K
Cytokine Growth Factor Rev; 2005; 16(4-5):495-512. PubMed ID: 15979924
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
[TBL] [Abstract][Full Text] [Related]
9. Sequential gonadotropin treatment of immature mice leads to amplification of transforming growth factor beta action, via upregulation of receptor-type 1, Smad 2 and 4, and downregulation of Smad 6.
Guéripel X; Benahmed M; Gougeon A
Biol Reprod; 2004 Mar; 70(3):640-8. PubMed ID: 14585817
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between the TGFbeta and Wnt signaling pathways in murine embryonic maxillary mesenchymal cells.
Warner DR; Greene RM; Pisano MM
FEBS Lett; 2005 Jul; 579(17):3539-46. PubMed ID: 15955531
[TBL] [Abstract][Full Text] [Related]
11. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
Mori Y; Chen SJ; Varga J
Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
Javelaud D; Mauviel A
Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
[TBL] [Abstract][Full Text] [Related]
13. [Cellular signaling in response to TGFbeta: the paradox of a factor that blocks cell proliferation and enhances metastasis].
Vignais ML
Bull Cancer; 1999 Nov; 86(11):903-10. PubMed ID: 10586106
[TBL] [Abstract][Full Text] [Related]
14. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
Tsang KJ; Tsang D; Brown TN; Crowe DL
Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
[TBL] [Abstract][Full Text] [Related]
15. TGFbeta inducible early gene enhances TGFbeta/Smad-dependent transcriptional responses.
Johnsen SA; Subramaniam M; Janknecht R; Spelsberg TC
Oncogene; 2002 Aug; 21(37):5783-90. PubMed ID: 12173049
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation.
Izzi L; Attisano L
Oncogene; 2004 Mar; 23(11):2071-8. PubMed ID: 15021894
[TBL] [Abstract][Full Text] [Related]
17. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterisation of a second structurally unusual AR-Smad without an MH1 domain and a Smad4 orthologue from Echinococcus multilocularis.
Zavala-Góngora R; Derrer B; Gelmedin V; Knaus P; Brehm K
Int J Parasitol; 2008 Feb; 38(2):161-76. PubMed ID: 17845804
[TBL] [Abstract][Full Text] [Related]
19. Novel regulation of Smad3 oligomerization and DNA binding by its linker domain.
Vasilaki E; Siderakis M; Papakosta P; Skourti-Stathaki K; Mavridou S; Kardassis D
Biochemistry; 2009 Sep; 48(35):8366-78. PubMed ID: 19645436
[TBL] [Abstract][Full Text] [Related]
20. Loss of expression, and mutations of Smad 2 and Smad 4 in human cervical cancer.
Maliekal TT; Antony ML; Nair A; Paulmurugan R; Karunagaran D
Oncogene; 2003 Jul; 22(31):4889-97. PubMed ID: 12894231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
